Literature DB >> 25473735

High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms.

Gaby Pons van Dijk, Elly van der Kooi, Anthony Behin, Joep Smeets, Janneke Timmermans, Silvère van der Maarel, George Padberg, Nicol Voermans, Baziel van Engelen.   

Abstract

The exact prevalence and nature of cardiac involvement in facioscapulohumeral muscular dystrophy (FSHD) is unknown. Nevertheless, the current opinion is that symptomatic cardiac disease is rare. We performed a cardiac screening [electrocardiogram (ECG) and echocardiography in the event of ECG abnormalities] in 75 genetically confirmed, ambulant FSHD patients without cardiac symptoms, with an eight-year follow-up of 57 patients, and compared the findings with results of previously performed cardiac screenings in the normal population. Baseline ECG demonstrated incomplete right bundle branch block (RBBB) in 33%, complete RBBB in 4%, and other minor abnormalities in 16%. Echocardiography showed no abnormalities. No significant changes were found after eight years of follow-up. Comparison with ECG abnormalities in the normal population showed a higher prevalence of incomplete RBBB (9.7 times higher) and of complete RBBB (4.8 times higher) in FSHD patients. This study in cardiac asymptomatic FSHD patients shows i) increased prevalence of incomplete RBBB in the absence of cardiomyopathy; ii) no progression of these abnormalities during eight years of follow-up. We conclude that FSHD patients without cardiac complaints do not need specific cardiac screening or surveillance. Furthermore, the increased prevalence of incomplete RBBB in the absence of cardiomyopathy suggests a selective involvement of the His-Purkinje system in FSHD.

Entities:  

Mesh:

Year:  2014        PMID: 25473735      PMCID: PMC4264782     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  26 in total

1.  PERSISTENT ATRIAL STANDSTILL.

Authors:  D A BLOOMFIELD; B C SINCLAIR-SMITH
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

2.  The electrocardiogram in population studies. A classification system.

Authors:  H BLACKBURN; A KEYS; E SIMONSON; P RAUTAHARJU; S PUNSAR
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

3.  Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy.

Authors:  Fabio Galetta; Ferdinando Franzoni; Roberto Sposito; Yvonne Plantinga; Francesca Romana Femia; Fabio Galluzzi; Anna Rocchi; Gino Santoro; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2005-04-21       Impact factor: 4.296

4.  Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.

Authors:  R J Osborne; S Welle; S L Venance; C A Thornton; R Tawil
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

5.  Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomography.

Authors:  P M Faustmann; J Farahati; B Rupilius; R Dux; M C Koch; C Reiners
Journal:  J Neurol Sci       Date:  1996-12       Impact factor: 3.181

6.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Authors:  William J Groh; Miriam R Groh; Chandan Saha; John C Kincaid; Zachary Simmons; Emma Ciafaloni; Rahman Pourmand; Richard F Otten; Deepak Bhakta; Girish V Nair; Mohammad M Marashdeh; Douglas P Zipes; Robert M Pascuzzi
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Bundle-branch block in a general male population: the study of men born 1913.

Authors:  P Eriksson; P O Hansson; H Eriksson; M Dellborg
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

Review 8.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

9.  Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy.

Authors:  P Laforêt; C de Toma; B Eymard; H M Becane; M Jeanpierre; M Fardeau; D Duboc
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

10.  Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia.

Authors:  Carlo Pietro Trevisan; Ebe Pastorello; Mario Armani; Corrado Angelini; Giovanni Nante; Giuliano Tomelleri; Paola Tonin; Tiziana Mongini; Laura Palmucci; Giuliana Galluzzi; Rossella G Tupler; Agata Barchitta
Journal:  Eur Neurol       Date:  2006-06-27       Impact factor: 1.710

View more
  9 in total

1.  Incomplete right bundle branch block: Challenges in electrocardiogram diagnosis.

Authors:  Mariana Floria; Noela Parteni; Alexandra Ioana Neagu; Radu Andy Sascau; Cristian Statescu; Daniela Maria Tanase
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

Review 2.  Facioscapulohumeral Muscular Dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Continuum (Minneap Minn)       Date:  2016-12

Review 3.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.

Authors:  Johanna Hamel; Rabi Tawil
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).

Authors:  Allison Ducharme-Smith; Stefan Nicolau; C Anwar A Chahal; Kirstie Ducharme-Smith; Shujah Rehman; Keerthi Jaliparthy; Nadeem Khan; Christopher G Scott; Erik K St Louis; Teerin Liewluck; Virend K Somers; Grace Lin; Peter A Brady; Margherita Milone
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

5.  Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).

Authors:  Rianne J M Goselink; Tim H A Schreuder; Karlien Mul; Nicol C Voermans; Maaike Pelsma; Imelda J M de Groot; Nens van Alfen; Bas Franck; Thomas Theelen; Richard J Lemmers; Jean K Mah; Silvère M van der Maarel; Baziel G van Engelen; Corrie E Erasmus
Journal:  BMC Neurol       Date:  2016-08-17       Impact factor: 2.474

6.  Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).

Authors:  Eugénie Ansseau; Céline Vanderplanck; Armelle Wauters; Scott Q Harper; Frédérique Coppée; Alexandra Belayew
Journal:  Genes (Basel)       Date:  2017-03-03       Impact factor: 4.096

7.  Evaluation of Myocardial Strain by 2-Dimensional Speckle Tracking Echocardiography in Patients with Facioscapulohumeral Muscular Dystrophy.

Authors:  Ferhat Işık; Abdurrahman Akyüz; Murat Çap; Askeri Türken; Süleyman Varsak; Erkan Baysal
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

Review 8.  DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.

Authors:  Kenji Rowel Q Lim; Quynh Nguyen; Toshifumi Yokota
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

9.  A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure.

Authors:  Nobutoshi Morimoto; Mizuki Morimoto; Yoshiaki Takahashi; Motonori Takamiya; Ichizo Nishino; Koji Abe
Journal:  eNeurologicalSci       Date:  2020-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.